Dynamic follow-up of smoldering multiple myeloma identifies a subset of patients at high risk of progression

Am J Hematol. 2021 Mar 1;96(3):E63-E65. doi: 10.1002/ajh.26062. Epub 2020 Dec 19.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers
  • Biomarkers, Tumor
  • Bone Marrow / pathology
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoglobulin kappa-Chains / blood
  • Immunoglobulin lambda-Chains / blood
  • Male
  • Middle Aged
  • Models, Biological
  • Multiple Myeloma / epidemiology*
  • Myeloma Proteins / analysis
  • Plasma Cells / pathology
  • Proportional Hazards Models
  • ROC Curve
  • Risk
  • Risk Assessment
  • Severity of Illness Index
  • Smoldering Multiple Myeloma / blood
  • Smoldering Multiple Myeloma / pathology*

Substances

  • Biomarkers
  • Biomarkers, Tumor
  • Immunoglobulin kappa-Chains
  • Immunoglobulin lambda-Chains
  • Myeloma Proteins